Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 6
1996 9
1997 7
1998 5
1999 6
2000 6
2001 10
2002 12
2003 10
2004 10
2005 7
2006 14
2007 16
2008 11
2009 15
2010 12
2011 17
2012 31
2013 33
2014 20
2015 29
2016 24
2017 15
2018 14
2019 9
2020 9
2021 16
2022 7
2023 6
2024 5
2025 8
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

363 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Early perioperative versus postoperative meloxicam for pain control in patients undergoing orthopedic surgery: a systematic review and Meta-analysis of randomized controlled trials.
Mahmoud A, Abuelazm M, Ashraf Salah Ahmed A, Elshinawy M, Ashour T, Abugdida M, Abdelazeem B. Mahmoud A, et al. Curr Med Res Opin. 2023 Jan;39(1):113-122. doi: 10.1080/03007995.2022.2135837. Epub 2022 Nov 4. Curr Med Res Opin. 2023. PMID: 36245362
Perioperative analgesia is administrating pre-emptive analgesia before and during the surgery followed by postoperative analgesia to decrease the procedure associated nociceptive response. We aim to assess perioperative meloxicam versus postoperative meloxicam for p …
Perioperative analgesia is administrating pre-emptive analgesia before and during the surgery followed by postoperative analgesia to decreas …
Bupivacaine-Meloxicam Extended-Release Solution Compared with a Standard Periarticular Injection in Primary Total Knee Arthroplasty: A Randomized Clinical Trial Showing Similar Efficacy in Postoperative Analgesia.
Salmons HI, Amundson AW, Duncan CM, Larson DR, Mallinger BD, Couch CG, Pagnano MW, Trousdale RT, Abdel MP. Salmons HI, et al. J Bone Joint Surg Am. 2025 Jul 25;107(17):1918-1925. doi: 10.2106/JBJS.25.00086. J Bone Joint Surg Am. 2025. PMID: 40711999 Clinical Trial.
Food and Drug Administration has approved a bupivacaine and meloxicam extended-release (ER) intra-articular injection for pain during total knee arthroplasty (TKA). ...Patients were blinded and were randomized 1:1 to the bupivacaine-meloxicam ER (ZYNRELEF) injection …
Food and Drug Administration has approved a bupivacaine and meloxicam extended-release (ER) intra-articular injection for pain during …
Efficacy and safety of 4-hydroxy 2-methyl-N-(5-methyl-2-thiazolyl)-2H-1, 2-benzothiazin-3-carboxamide 1,1-dioxide, a fast-acting meloxicam formulation, on moderate-to-severe pain following abdominal surgery: A phase III randomized controlled trial.
Liu X, Zhao Y, Yang M, Ren J, Ouyang W, Wang S, Shen Y, Gao Y, Zhao L, Qin Z, Cao J, Xia J, Zhou H, Zeng H, Li J, Li Q, Jiang H, Zhou R, Yuan K, Jin S, Zhang X, Wang C, Chen Y, Dong H, Lv J, Yu S, Jiu Y, Wang Q, Su D, Yu W. Liu X, et al. Clin Transl Sci. 2024 Dec;17(12):e70081. doi: 10.1111/cts.70081. Clin Transl Sci. 2024. PMID: 39660482 Free PMC article. Clinical Trial.
4-hydroxy 2-methyl-N-(5-methyl-2-thiazolyl)-2H-1, 2-benzothiazin-3-carboxamide 1,1-dioxide (QP001), a novel long-lasting meloxicam formulation, may provide adequate postoperative pain relief with a good safety profile. ...
4-hydroxy 2-methyl-N-(5-methyl-2-thiazolyl)-2H-1, 2-benzothiazin-3-carboxamide 1,1-dioxide (QP001), a novel long-lasting meloxicam fo …
Efficacy and safety of 4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1, 2-benzothiazin-3-carboxamide 1,1-dioxide, a rapid-acting meloxicam formulation, for analgesia after orthopaedic surgery under general anaesthesia: a randomized controlled trial.
Zhou Y, Jiang Y, Duan K, Li Q, Yang M, Lei Q, Bao M, Xie G, Sun J, Chen L, Zhou H, Zhang Y, Huang Y, Gao Y, Han L, Lin H, Zhang Y, Chen Y, Zhao L, Chen S, Chen C, Jiang H, Ren J, Ouyang W, Tang S, Wang S. Zhou Y, et al. Inflammopharmacology. 2024 Dec;32(6):3799-3808. doi: 10.1007/s10787-024-01575-z. Epub 2024 Oct 14. Inflammopharmacology. 2024. PMID: 39397127 Clinical Trial.
Gastrointestinal safety profile of meloxicam: a meta-analysis and systematic review of randomized controlled trials.
Schoenfeld P. Schoenfeld P. Am J Med. 1999 Dec 13;107(6A):48S-54S. doi: 10.1016/s0002-9343(99)00367-8. Am J Med. 1999. PMID: 10628593
Meloxicam, a COX-2-selective NSAID, appears to cause fewer adverse GI events than standard, non-COX-2-selective NSAIDs. However, the generalizability of these data may be limited by the low dose of meloxicam used in most trials and the use of the WHO-ARTL to code ad …
Meloxicam, a COX-2-selective NSAID, appears to cause fewer adverse GI events than standard, non-COX-2-selective NSAIDs. However, the …
Pharmacokinetics of Meloxicam Tablets in Healthy Chinese Adults in the Fasting and Fed States: A Single-Site, Single-Dose, Randomized, Open, 2-Period, 2-Sequence, Crossover Bioequivalence Study.
Yu J, Wang Y, Wu Y, Lin S, Hao R, Fang L, Zhu J, Zhao D, Tong S, Si Y, Ye T, Wu Z, Huang H, Zhou F, Wang Y. Yu J, et al. Clin Pharmacol Drug Dev. 2022 Jan;11(1):71-79. doi: 10.1002/cpdd.965. Epub 2021 Jun 17. Clin Pharmacol Drug Dev. 2022. PMID: 34137514 Clinical Trial.
Meloxicam is an enolate nonsteroidal anti-inflammatory agent. This trial investigated the pharmacokinetics, safety, and bioequivalence of single oral doses of Aomei meloxicam (15 mg) and Mobic meloxicam (15 mg) in healthy volunteers under fasting and fed cond …
Meloxicam is an enolate nonsteroidal anti-inflammatory agent. This trial investigated the pharmacokinetics, safety, and bioequivalenc …
Clinical pharmacokinetics of meloxicam.
Türck D, Busch U, Heinzel G, Narjes H. Türck D, et al. Arzneimittelforschung. 1997 Mar;47(3):253-8. Arzneimittelforschung. 1997. PMID: 9105543 Clinical Trial.
Plasma concentrations of meloxicam were determined by validated high performance liquid chromatography (HPLC) methods. ...Meloxicam is metabolized to four biologically inactive metabolites and excreted in urine and faeces with an elimination half-life (t1/2) of arou …
Plasma concentrations of meloxicam were determined by validated high performance liquid chromatography (HPLC) methods. ...Meloxica …
Economic Impact of Preoperative Meloxicam IV Administration in Total Knee Arthroplasty: A Randomized Trial Sub-Study.
Berkowitz RD, Steinfeld R, Sah AP, Anupindi VR, Shah D, DeKoven M, Coyle K, McCallum SW, Mack R, Coyle E, Freyer A, Du W, Black LK. Berkowitz RD, et al. J Pain Palliat Care Pharmacother. 2021 Sep;35(3):150-162. doi: 10.1080/15360288.2021.1883789. Epub 2021 Jul 19. J Pain Palliat Care Pharmacother. 2021. PMID: 34280067 Free article. Clinical Trial.
Data on total hospital costs and length of stay (LOS) obtained from the trial were compared between meloxicam IV 30 mg and placebo groups. Patients in the meloxicam IV 30 mg vs placebo group (n = 93 vs 88) incurred an adjusted $2,266 (95% CI: -$1,035, $5,116; p = 0. …
Data on total hospital costs and length of stay (LOS) obtained from the trial were compared between meloxicam IV 30 mg and placebo gr …
363 results